Veritas In Silico Inc. (JP:130A) has released an update.
Veritas In Silico Inc. is focused on expanding its platform business for mRNA-targeted drug discovery through strategic contracts and in-house pipeline creation. The company aims to enhance shareholder value by transitioning into a specialty pharmaceutical company with a balanced approach of revenue generation and investment.
For further insights into JP:130A stock, check out TipRanks’ Stock Analysis page.